About Us | Contact

Dr. Barbara Andrea Diaz Hernandez Investigator

Psychiatry Spectrum Health Pennock NPI1366486961
Update NPI

Open Payments

Note

The following payment details are based on a national transparency program known as the Sunshine Act that collects and publishes information about financial relationships between the health care industry (i.e. drug and device manufactures) and providers. These relationships may involve payment to providers for things such as research, speaking engagment, travel, gifts etc. Not all of these payment involve monetary compensations and may include batering of drugs or devices.

Total Payment Worth

$17,420.55
from 32 payments in the last 6 years

Total Cash or Cash Equivalent

$15,589.05
from 16 payments in the last 6 years

Total In-kind Items & Services

$1,831.50
from 16 payments in the last 6 years

Nature of Payments

Last 6 Years
Chart will render here...

Yearly Breakdown

Chart will render here...

Payment Details

Date Payment Type Form of Payment Item/Service Payment Amount
09/21/2017 Research Cash or cash equivalent $5154.70 Details
Payment from Allergan Inc.
Paymment Research Study A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP, MULTICENTER, FIXED-DOSE CLINICAL TRIAL EVALUATING THE EFFICACY, SAFETY AND TOLERABILITY OF CARIPRAZINE IN PATIENTS WITH BIPOLAR I DEPRESSION
Payment Record ID 463923317
12/31/2017 Research Cash or cash equivalent Drug $672.60 Details
Payment from Allergan Inc.
Paymment Research Study A DOUBLE BLIND, PLACEBO- AND ACTIVE CONTROLLED EVALUATION OF THE SAFETY AND EFFICACY OF LEVOMILNACIPRAN ER IN ADOLESCENT PATIENTS WITH MAJOR DEPRESSIVE DISORDER
Payment Record ID 463923301
04/27/2016 Research Cash or cash equivalent Drug $20.00 Details
Payment from Allergan Inc.
Paymment Research Study AN OPEN LABEL, LONG-TERM STUDY TO ASSESS THE IMMUNOGENICITY OF LINACLOTIDE ADMINISTERED ORALLY TO ADULT PATIENTS WITH IRRITABLE BOWEL SYNDROME WITH CONSTIPATION OR CHRONIC IDIOPATHIC CONSTIPATION
Payment Record ID 403743036
04/27/2016 Research Cash or cash equivalent Drug $22.00 Details
Payment from Allergan Inc.
Paymment Research Study AN OPEN LABEL, LONG-TERM STUDY TO ASSESS THE IMMUNOGENICITY OF LINACLOTIDE ADMINISTERED ORALLY TO ADULT PATIENTS WITH IRRITABLE BOWEL SYNDROME WITH CONSTIPATION OR CHRONIC IDIOPATHIC CONSTIPATION
Payment Record ID 403743028
05/04/2016 Research In-kind items and services Drug $33.00 Details
Payment from Allergan Inc.
Paymment Research Study AN OPEN LABEL, LONG-TERM STUDY TO ASSESS THE IMMUNOGENICITY OF LINACLOTIDE ADMINISTERED ORALLY TO ADULT PATIENTS WITH IRRITABLE BOWEL SYNDROME WITH CONSTIPATION OR CHRONIC IDIOPATHIC CONSTIPATION
Payment Record ID 403743012
05/02/2016 Research In-kind items and services Drug $33.00 Details
Payment from Allergan Inc.
Paymment Research Study AN OPEN LABEL, LONG-TERM STUDY TO ASSESS THE IMMUNOGENICITY OF LINACLOTIDE ADMINISTERED ORALLY TO ADULT PATIENTS WITH IRRITABLE BOWEL SYNDROME WITH CONSTIPATION OR CHRONIC IDIOPATHIC CONSTIPATION
Payment Record ID 403743008
05/04/2016 Research In-kind items and services Drug $33.00 Details
Payment from Allergan Inc.
Paymment Research Study AN OPEN LABEL, LONG-TERM STUDY TO ASSESS THE IMMUNOGENICITY OF LINACLOTIDE ADMINISTERED ORALLY TO ADULT PATIENTS WITH IRRITABLE BOWEL SYNDROME WITH CONSTIPATION OR CHRONIC IDIOPATHIC CONSTIPATION
Payment Record ID 403743004
07/01/2016 Research In-kind items and services Drug $40.00 Details
Payment from Allergan Inc.
Paymment Research Study AN OPEN LABEL, LONG-TERM STUDY TO ASSESS THE IMMUNOGENICITY OF LINACLOTIDE ADMINISTERED ORALLY TO ADULT PATIENTS WITH IRRITABLE BOWEL SYNDROME WITH CONSTIPATION OR CHRONIC IDIOPATHIC CONSTIPATION
Payment Record ID 403742998
08/08/2016 Research In-kind items and services Drug $55.00 Details
Payment from Allergan Inc.
Paymment Research Study AN OPEN LABEL, LONG-TERM STUDY TO ASSESS THE IMMUNOGENICITY OF LINACLOTIDE ADMINISTERED ORALLY TO ADULT PATIENTS WITH IRRITABLE BOWEL SYNDROME WITH CONSTIPATION OR CHRONIC IDIOPATHIC CONSTIPATION
Payment Record ID 403742994
08/08/2016 Research In-kind items and services Drug $55.00 Details
Payment from Allergan Inc.
Paymment Research Study AN OPEN LABEL, LONG-TERM STUDY TO ASSESS THE IMMUNOGENICITY OF LINACLOTIDE ADMINISTERED ORALLY TO ADULT PATIENTS WITH IRRITABLE BOWEL SYNDROME WITH CONSTIPATION OR CHRONIC IDIOPATHIC CONSTIPATION
Payment Record ID 403742990
04/27/2016 Research Cash or cash equivalent Drug $75.00 Details
Payment from Allergan Inc.
Paymment Research Study AN OPEN LABEL, LONG-TERM STUDY TO ASSESS THE IMMUNOGENICITY OF LINACLOTIDE ADMINISTERED ORALLY TO ADULT PATIENTS WITH IRRITABLE BOWEL SYNDROME WITH CONSTIPATION OR CHRONIC IDIOPATHIC CONSTIPATION
Payment Record ID 403742986
06/15/2016 Research In-kind items and services Drug $77.00 Details
Payment from Allergan Inc.
Paymment Research Study AN OPEN LABEL, LONG-TERM STUDY TO ASSESS THE IMMUNOGENICITY OF LINACLOTIDE ADMINISTERED ORALLY TO ADULT PATIENTS WITH IRRITABLE BOWEL SYNDROME WITH CONSTIPATION OR CHRONIC IDIOPATHIC CONSTIPATION
Payment Record ID 403742978
06/15/2016 Research In-kind items and services Drug $105.00 Details
Payment from Allergan Inc.
Paymment Research Study AN OPEN LABEL, LONG-TERM STUDY TO ASSESS THE IMMUNOGENICITY OF LINACLOTIDE ADMINISTERED ORALLY TO ADULT PATIENTS WITH IRRITABLE BOWEL SYNDROME WITH CONSTIPATION OR CHRONIC IDIOPATHIC CONSTIPATION
Payment Record ID 403742974
04/27/2016 Research Cash or cash equivalent Drug $110.00 Details
Payment from Allergan Inc.
Paymment Research Study AN OPEN LABEL, LONG-TERM STUDY TO ASSESS THE IMMUNOGENICITY OF LINACLOTIDE ADMINISTERED ORALLY TO ADULT PATIENTS WITH IRRITABLE BOWEL SYNDROME WITH CONSTIPATION OR CHRONIC IDIOPATHIC CONSTIPATION
Payment Record ID 403742970
08/08/2016 Research In-kind items and services Drug $150.00 Details
Payment from Allergan Inc.
Paymment Research Study AN OPEN LABEL, LONG-TERM STUDY TO ASSESS THE IMMUNOGENICITY OF LINACLOTIDE ADMINISTERED ORALLY TO ADULT PATIENTS WITH IRRITABLE BOWEL SYNDROME WITH CONSTIPATION OR CHRONIC IDIOPATHIC CONSTIPATION
Payment Record ID 403742966
07/01/2016 Research In-kind items and services Drug $150.00 Details
Payment from Allergan Inc.
Paymment Research Study AN OPEN LABEL, LONG-TERM STUDY TO ASSESS THE IMMUNOGENICITY OF LINACLOTIDE ADMINISTERED ORALLY TO ADULT PATIENTS WITH IRRITABLE BOWEL SYNDROME WITH CONSTIPATION OR CHRONIC IDIOPATHIC CONSTIPATION
Payment Record ID 403742962
04/27/2016 Research Cash or cash equivalent $36.00 Details
Payment from Allergan Inc.
Paymment Research Study A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP, MULTICENTER, FIXED-DOSE CLINICAL TRIAL EVALUATING THE EFFICACY, SAFETY AND TOLERABILITY OF CARIPRAZINE IN PATIENTS WITH BIPOLAR I DEPRESSION
Payment Record ID 403742956
04/27/2016 Research Cash or cash equivalent $47.00 Details
Payment from Allergan Inc.
Paymment Research Study A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP, MULTICENTER, FIXED-DOSE CLINICAL TRIAL EVALUATING THE EFFICACY, SAFETY AND TOLERABILITY OF CARIPRAZINE IN PATIENTS WITH BIPOLAR I DEPRESSION
Payment Record ID 403742952
05/09/2016 Research In-kind items and services $70.50 Details
Payment from Allergan Inc.
Paymment Research Study A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP, MULTICENTER, FIXED-DOSE CLINICAL TRIAL EVALUATING THE EFFICACY, SAFETY AND TOLERABILITY OF CARIPRAZINE IN PATIENTS WITH BIPOLAR I DEPRESSION
Payment Record ID 403742948
04/25/2016 Research In-kind items and services $125.00 Details
Payment from Allergan Inc.
Paymment Research Study A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP, MULTICENTER, FIXED-DOSE CLINICAL TRIAL EVALUATING THE EFFICACY, SAFETY AND TOLERABILITY OF CARIPRAZINE IN PATIENTS WITH BIPOLAR I DEPRESSION
Payment Record ID 403742944
05/09/2016 Research In-kind items and services $125.00 Details
Payment from Allergan Inc.
Paymment Research Study A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP, MULTICENTER, FIXED-DOSE CLINICAL TRIAL EVALUATING THE EFFICACY, SAFETY AND TOLERABILITY OF CARIPRAZINE IN PATIENTS WITH BIPOLAR I DEPRESSION
Payment Record ID 403742940
04/27/2016 Research Cash or cash equivalent $125.00 Details
Payment from Allergan Inc.
Paymment Research Study A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP, MULTICENTER, FIXED-DOSE CLINICAL TRIAL EVALUATING THE EFFICACY, SAFETY AND TOLERABILITY OF CARIPRAZINE IN PATIENTS WITH BIPOLAR I DEPRESSION
Payment Record ID 403742936
04/27/2016 Research Cash or cash equivalent $125.00 Details
Payment from Allergan Inc.
Paymment Research Study A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP, MULTICENTER, FIXED-DOSE CLINICAL TRIAL EVALUATING THE EFFICACY, SAFETY AND TOLERABILITY OF CARIPRAZINE IN PATIENTS WITH BIPOLAR I DEPRESSION
Payment Record ID 403742934
05/09/2016 Research In-kind items and services $375.00 Details
Payment from Allergan Inc.
Paymment Research Study A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP, MULTICENTER, FIXED-DOSE CLINICAL TRIAL EVALUATING THE EFFICACY, SAFETY AND TOLERABILITY OF CARIPRAZINE IN PATIENTS WITH BIPOLAR I DEPRESSION
Payment Record ID 403742930
05/09/2016 Research In-kind items and services $375.00 Details
Payment from Allergan Inc.
Paymment Research Study A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP, MULTICENTER, FIXED-DOSE CLINICAL TRIAL EVALUATING THE EFFICACY, SAFETY AND TOLERABILITY OF CARIPRAZINE IN PATIENTS WITH BIPOLAR I DEPRESSION
Payment Record ID 403742926
03/23/2016 Research Cash or cash equivalent $75.00 Details
Payment from Allergan Inc.
Paymment Research Study A PHASE 3, LONG-TERM, OPEN-LABEL STUDY OF SAFETY AND TOLERABILITY OF CARIPRAZINE AS ADJUNCTIVE THERAPY IN MAJOR DEPRESSIVE DISORDER
Payment Record ID 403742924
09/26/2016 Research Cash or cash equivalent $3426.75 Details
Payment from Allergan Inc.
Paymment Research Study A PHASE 3, LONG-TERM, OPEN-LABEL STUDY OF SAFETY AND TOLERABILITY OF CARIPRAZINE AS ADJUNCTIVE THERAPY IN MAJOR DEPRESSIVE DISORDER
Payment Record ID 403742920
03/25/2016 Research Cash or cash equivalent $450.00 Details
Payment from Allergan Inc.
Paymment Research Study A PHASE 3, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF CARIPRAZINE AS ADJUNCTIVE THERAPY IN MAJOR DEPRESSIVE DISORDER MDD
Payment Record ID 403742916
03/25/2016 Research Cash or cash equivalent $2500.00 Details
Payment from Allergan Inc.
Paymment Research Study A PHASE 3, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF CARIPRAZINE AS ADJUNCTIVE THERAPY IN MAJOR DEPRESSIVE DISORDER MDD
Payment Record ID 403742910
03/25/2016 Research Cash or cash equivalent $2500.00 Details
Payment from Allergan Inc.
Paymment Research Study A PHASE 3, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF CARIPRAZINE AS ADJUNCTIVE THERAPY IN MAJOR DEPRESSIVE DISORDER MDD
Payment Record ID 403742906
05/09/2016 Research In-kind items and services Drug $30.00 Details
Payment from Allergan Inc.
Paymment Research Study A DOUBLE BLIND, PLACEBO- AND ACTIVE CONTROLLED EVALUATION OF THE SAFETY AND EFFICACY OF LEVOMILNACIPRAN ER IN ADOLESCENT PATIENTS WITH MAJOR DEPRESSIVE DISORDER
Payment Record ID 403742896
12/13/2016 Research Cash or cash equivalent $250.00 Details
Payment from Allergan Inc.
Paymment Research Study A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP, MULTICENTER, FIXED-DOSE CLINICAL TRIAL EVALUATING THE EFFICACY, SAFETY AND TOLERABILITY OF CARIPRAZINE IN PATIENTS WITH BIPOLAR I DEPRESSION
Payment Record ID 403727048
;